Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

272 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
More tasks for Dna2 in S-phase.
Aparicio T, Gautier J. Aparicio T, et al. Cell Cycle. 2012 Dec 1;11(23):4299-300. doi: 10.4161/cc.22807. Epub 2012 Nov 16. Cell Cycle. 2012. PMID: 23159855 Free PMC article. No abstract available.
DNA double-strand break repair pathway choice and cancer.
Aparicio T, Baer R, Gautier J. Aparicio T, et al. DNA Repair (Amst). 2014 Jul;19:169-75. doi: 10.1016/j.dnarep.2014.03.014. Epub 2014 Apr 18. DNA Repair (Amst). 2014. PMID: 24746645 Free PMC article. Review.
Inhibition of DNA replication initiation by silver nanoclusters.
Tao Y, Aparicio T, Li M, Leong KW, Zha S, Gautier J. Tao Y, et al. Among authors: aparicio t. Nucleic Acids Res. 2021 May 21;49(9):5074-5083. doi: 10.1093/nar/gkab271. Nucleic Acids Res. 2021. PMID: 33905520 Free PMC article.
Nuclear ARP2/3 drives DNA break clustering for homology-directed repair.
Schrank BR, Aparicio T, Li Y, Chang W, Chait BT, Gundersen GG, Gottesman ME, Gautier J. Schrank BR, et al. Among authors: aparicio t. Nature. 2018 Jul;559(7712):61-66. doi: 10.1038/s41586-018-0237-5. Epub 2018 Jun 20. Nature. 2018. PMID: 29925947 Free PMC article.
Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databases.
Aparicio T, Henriques J, Svrcek M, Zaanan A, Manfredi S, Casadei-Gardini A, Tougeron D, Gornet JM, Jary M, Terrebonne E, Piessen G, Afchain P, Lecaille C, Pocard M, Lecomte T, Rimini M, Di Fiore F, Le Brun Ly V, Cascinu S, Vernerey D, Laurent Puig P. Aparicio T, et al. Br J Cancer. 2024 May 14. doi: 10.1038/s41416-024-02687-7. Online ahead of print. Br J Cancer. 2024. PMID: 38745088
First-Line LV5FU2 with or without Aflibercept in Patients with Non-Resectable Metastatic Colorectal Cancer: A Randomized Phase II Trial (PRODIGE 25-FFCD-FOLFA).
Legoux JL, Faroux R, Barrière N, Le Malicot K, Tougeron D, Lorgis V, Guerin-Meyer V, Bourgeois V, Malka D, Aparicio T, Baconnier M, Lebrun-Ly V, Egreteau J, Khemissa Akouz F, Terme M, Lepage C, Boige V. Legoux JL, et al. Among authors: aparicio t. Cancers (Basel). 2024 Apr 16;16(8):1515. doi: 10.3390/cancers16081515. Cancers (Basel). 2024. PMID: 38672597 Free PMC article.
FOLFIRI Plus Durvalumab With or Without Tremelimumab in Second-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: The PRODIGE 59-FFCD 1707-DURIGAST Randomized Clinical Trial.
Tougeron D, Dahan L, Evesque L, Le Malicot K, El Hajbi F, Aparicio T, Bouché O, Bonichon Lamichhane N, Chibaudel B, Angelergues A, Bodere A, Phelip JM, Mabro M, Kaluzinski L, Petorin C, Breysacher G, Rinaldi Y, Zaanan A, Smith D, Gouttebel MC, Perret C, Etchepare N, Emile JF, Sanfourche I, Di Fiore F, Lepage C, Artru P, Louvet C; PRODIGE 59-FFCD 1707-DURIGAST Investigators/Collaborators. Tougeron D, et al. Among authors: aparicio t. JAMA Oncol. 2024 Apr 4. doi: 10.1001/jamaoncol.2024.0207. Online ahead of print. JAMA Oncol. 2024. PMID: 38573643
272 results